sorbitan sesquioleate structure
|
Common Name | sorbitan sesquioleate | ||
---|---|---|---|---|
CAS Number | 8007-43-0 | Molecular Weight | 1175.70000 | |
Density | 0.993g/cm3 | Boiling Point | 738.7ºC at 760 mmHg | |
Molecular Formula | C66H126O16 | Melting Point | N/A | |
MSDS | Chinese USA | Flash Point | 205.1ºC |
Name | Span 83 (=Sorbitan Sesquioleate) |
---|---|
Synonym | More Synonyms |
Density | 0.993g/cm3 |
---|---|
Boiling Point | 738.7ºC at 760 mmHg |
Molecular Formula | C66H126O16 |
Molecular Weight | 1175.70000 |
Flash Point | 205.1ºC |
Exact Mass | 1174.90000 |
PSA | 292.20000 |
LogP | 13.24590 |
Appearance of Characters | Viscous Liquid | Pale Yellow |
Vapour Pressure | 0.81 psi ( 20 °C) |
Index of Refraction | 1.493 |
Water Solubility | Dispersible in water, soluble in fatty oils, slightly soluble in ethanol. | Insoluble in cold water, hot water. soluble in mineral oil and ethyl acetate. |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
Personal Protective Equipment | Eyeshields;Gloves;half-mask respirator (US);multi-purpose combination respirator cartridge (US) |
---|---|
Safety Phrases | S23;S24/25 |
RIDADR | NONH for all modes of transport |
WGK Germany | 1 |
RTECS | WG2934330 |
Contact allergy to sorbitans: a follow-up study.
Dermatitis 23(4) , 158-61, (2012) Sorbitan sesquioleate (SSO), an emulsifier in many corticosteroids, was previously found positive in 8.9% of 112 dermatitis patients.The objective of this study was to present data on 24 of 591 dermat... |
|
Allergens in corticosteroid vehicles.
Dermatitis 19(1) , 38-42, (2008) Whereas allergy to vehicle ingredients (ie, excipients and preservatives) in topical steroid vehicles is well recognized, there are no data regarding which vehicle ingredients are in common use or on ... |
|
Relation between antigen release and immune response of oil adjuvanted vaccines in chickens.
J. Vet. Med. Sci. 62(6) , 571-4, (2000) The relationship between release properties of the model antigen, bovine serum albumin (BSA), from formulations in vitro and immune response after administration of various oil adjuvanted vaccines con... |
MFCD00151568 |
sorbitan sesquioleate |
EINECS 232-360-1 |